endocrinology
Type 2 diabetes

DKA risk when keto diet is combined with SGLT2 inhibitor

The risk of ketoacidosis from an SGLT2 inhibitor is exacerbated by a ketogenic diet, clinicians in Tasmania have warned. A woman with type 2 diabetes who started on the Atkins diet while taking empagliflozin developed euglycaemic ketoacidosis and had to be hospitalised, according to a case report from Dr Shampa Sinha and colleagues from the ...

Already a member?

Login to keep reading.


OR
© 2021 the limbic